15 min read
Peptide Pricing Truth: Why You Are Paying 300% Too Much
A factory-to-clinic peptide cost audit covering SPPS yield, purification loss, analytical release, vial filling, broker layers, landed DDP cost, low-MOQ validation and margin risk.
Peptide Pricing Truth: Factory-Direct vs. Resellers
Exposing the 300% to 500% local distributor markup. Real manufacturing costs, scale tiers, and eliminating the middleman.
Read article